Rick Starrs, CEO of NAVREF When it comes to clinical research trials, America leads the world in providing patients with access to the latest, state-of-the-art care. However, an under-represented population in clinical studies might surprise you: veterans. To correct this shortfall,…

By 2040, experts say the number of yearly cancer cases in Africa will double. In 2018 alone, cancer deaths in Africa (over 530,000) were 30 percent higher than deaths from malaria. Clearly, a shift in disease burdens has taken place on the continent. Biotechnology and pharmaceutical companies are…

Representing all facets of the patient stakeholder community, participants in BIO’s eighth Patient and Health Advocacy Summit (#BIOSummit19) came together to proclaim: “I am BIO.” But as Dr. Julie Gerberding, executive vice president and chief patent officer at Merck and Co., who acted as the event…

For the FDA, engagement with patients, caregivers and patient advocacy organizations is a vital part of the drug development and review process. However, how that engagement happens can determine how successful it is. This was the key question addressed by the “Practices and Principles: Navigating…

Writing for the Boston Globe, Dr. Michael Rosenblatt, chief medical officer of the venture firm Flagship Pioneering, debunks the common myth that biopharmaceutical companies are “free-riding” on government research. Policymakers in Washington have long preferred to believe that scientists and…

BIO is out with a new whiteboard video that explores why more and more patients are facing higher costs when they go to the pharmacy to buy their prescription drugs. See how rebates and discounts within the drug cost ecosystem are often not used by insurers to lower patients’ out-of-pocket drug…

Some 95 percent of cancer drugs launched around the globe are available in the U.S. Given that the U.S. is a global leader in ensuring patients have access to the newest therapies, the country has a profound impact on patient treatment and outcomes around the world. During the panel, Global…

Placing patients at the center of everything the biotech industry stands for is a personal mission for Christi Shaw. In 1996, her mother, Karen, died of breast cancer. It was a tragic time for her and her two sisters. But tragedy would strike again as Christi’s sister, Sherry, was later diagnosed…

When pop star Demi Lovato experienced an apparent opioid-related overdose last summer, reports stated that she was saved by a medication called NARCAN® Nasal Spray — the first FDA-approved nasal form of naloxone, an opioid antagonist. The company that developed NARCAN® Nasal Spray is Opiant…

In October of 2018, the Trump Administration outlined a proposal that would import foreign price controls for medicines covered under Medicare Part B. Despite warnings from BIO and dozens of other industry experts and patient advocates, the administration continues to defend its flawed plan and…